196 related articles for article (PubMed ID: 33025640)
1. Predicting likelihood of in vivo chemotherapy response in canine lymphoma using ex vivo drug sensitivity and immunophenotyping data in a machine learning model.
Bohannan Z; Pudupakam RS; Koo J; Horwitz H; Tsang J; Polley A; Han EJ; Fernandez E; Park S; Swartzfager D; Qi NSX; Tu C; Rankin WV; Thamm DH; Lee HR; Lim S
Vet Comp Oncol; 2021 Mar; 19(1):160-171. PubMed ID: 33025640
[TBL] [Abstract][Full Text] [Related]
2. Flow cytometric immunophenotype of canine lymph node aspirates.
Gibson D; Aubert I; Woods JP; Abrams-Ogg A; Kruth S; Wood RD; Bienzle D
J Vet Intern Med; 2004; 18(5):710-7. PubMed ID: 15515589
[TBL] [Abstract][Full Text] [Related]
3. Possibilities of flow cytometric analysis for immunophenotypic characterization of canine lymphoma.
Culmsee K; Simon D; Mischke R; Nolte I
J Vet Med A Physiol Pathol Clin Med; 2001 May; 48(4):199-206. PubMed ID: 11413979
[TBL] [Abstract][Full Text] [Related]
4. Cytometric evaluation of peripheral blood lymphocytes in dogs with lymphoma during chemotherapy.
Winnicka A; Jagielski D; Hoffmann-Jagielska M; Lechowski R
J Vet Med A Physiol Pathol Clin Med; 2002 Aug; 49(6):303-6. PubMed ID: 12227473
[TBL] [Abstract][Full Text] [Related]
5. Use of fine needle aspirates and flow cytometry for the diagnosis, classification, and immunophenotyping of canine lymphomas.
Sözmen M; Tasca S; Carli E; De Lorenzi D; Furlanello T; Caldin M
J Vet Diagn Invest; 2005 Jul; 17(4):323-30. PubMed ID: 16130989
[TBL] [Abstract][Full Text] [Related]
6. Combination chemotherapy with vincristine, cyclophosphamide, and prednisone producing long-term remission of a transplanted canine lymphoma.
Cohen H; Schmidt CE; Lucas SR; Palmer JL
Am J Vet Res; 1975 Oct; 36(10):1483-7. PubMed ID: 1238040
[TBL] [Abstract][Full Text] [Related]
7. Sequential low-dose rate half-body irradiation and chemotherapy for the treatment of canine multicentric lymphoma.
Lurie DM; Gordon IK; Théon AP; Rodriguez CO; Suter SE; Kent MS
J Vet Intern Med; 2009; 23(5):1064-70. PubMed ID: 19627472
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA profiling in canine multicentric lymphoma.
Craig KKL; Wood GA; Keller SM; Mutsaers AJ; Wood RD
PLoS One; 2019; 14(12):e0226357. PubMed ID: 31826004
[TBL] [Abstract][Full Text] [Related]
9. Rabacfosadine for naïve canine intermediate to large cell lymphoma: Efficacy and adverse event profile across three prospective clinical trials.
Saba CF; Clifford C; Burgess K; Phillips B; Vail D; Wright Z; Curran K; Fan T; Elmslie R; Post G; Thamm D
Vet Comp Oncol; 2020 Dec; 18(4):763-769. PubMed ID: 32346934
[TBL] [Abstract][Full Text] [Related]
10. Argyrophilic nucleolar organizing regions and Ki67 equally reflect proliferation in fine needle aspirates of normal, hyperplastic, inflamed, and neoplastic canine lymph nodes (n = 101).
Bauer NB; Zervos D; Moritz A
J Vet Intern Med; 2007; 21(5):928-35. PubMed ID: 17939545
[TBL] [Abstract][Full Text] [Related]
11. Canine lymphoma: immunocytochemical analysis of fine-needle aspiration biopsy.
Caniatti M; Roccabianca P; Scanziani E; Paltrinieri S; Moore PF
Vet Pathol; 1996 Mar; 33(2):204-12. PubMed ID: 8801714
[TBL] [Abstract][Full Text] [Related]
12. High content imaging for the morphometric diagnosis and immunophenotypic prognosis of canine lymphomas.
Papakonstantinou S; O'Brien PJ
Cytometry B Clin Cytom; 2014 Nov; 86(6):373-82. PubMed ID: 25044888
[TBL] [Abstract][Full Text] [Related]
13. Validation of an immunocytochemical assay for immunophenotyping of lymphoma in guinea pigs (Cavia porcellus).
Evans SJM; Harr KE; Thielen L; MacNeill AL
Vet Clin Pathol; 2018 Dec; 47(4):682-687. PubMed ID: 30358180
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of morphological subtypes in canine malignant lymphomas during chemotherapy.
Ponce F; Magnol JP; Ledieu D; Marchal T; Turinelli V; Chalvet-Monfray K; Fournel-Fleury C
Vet J; 2004 Mar; 167(2):158-66. PubMed ID: 14975390
[TBL] [Abstract][Full Text] [Related]
15. Alternating Rabacfosadine/Doxorubicin: Efficacy and Tolerability in Naïve Canine Multicentric Lymphoma.
Thamm DH; Vail DM; Post GS; Fan TM; Phillips BS; Axiak-Bechtel S; Elmslie RS; Klein MK; Ruslander DA
J Vet Intern Med; 2017 May; 31(3):872-878. PubMed ID: 28370378
[TBL] [Abstract][Full Text] [Related]
16. Gamma delta T-cell large granular lymphocyte lymphoma in a dog.
Ortiz AL; Carvalho S; Leo C; Riondato F; Archer J; Cian F
Vet Clin Pathol; 2015 Sep; 44(3):442-7. PubMed ID: 25965815
[TBL] [Abstract][Full Text] [Related]
17. Combination chemotherapy with L-asparaginase, lomustine, and prednisone for relapsed or refractory canine lymphoma.
Saba CF; Thamm DH; Vail DM
J Vet Intern Med; 2007; 21(1):127-32. PubMed ID: 17338160
[TBL] [Abstract][Full Text] [Related]
18. Composition of lymphocyte subpopulations in normal canine lymph nodes.
Rütgen BC; König R; Hammer SE; Groiss S; Saalmüller A; Schwendenwein I
Vet Clin Pathol; 2015 Mar; 44(1):58-69. PubMed ID: 25512102
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors for treated canine malignant lymphoma.
Kiupel M; Teske E; Bostock D
Vet Pathol; 1999 Jul; 36(4):292-300. PubMed ID: 10421095
[TBL] [Abstract][Full Text] [Related]
20. Combination chemotherapy with continuous L-asparaginase, lomustine, and prednisone for relapsed canine lymphoma.
Saba CF; Hafeman SD; Vail DM; Thamm DH
J Vet Intern Med; 2009; 23(5):1058-63. PubMed ID: 19678892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
